Recursion Pharmaceuticals

Recursion Pharmaceuticals

Recursion Pharmaceuticals

Combining experimental biology and bioinformatics to identify 100 new treatmentsin 10 years.
Type
B2c
Founded
2013
Raised
$100.6M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$20,500,000
Debt financing - 2018
Square 1 Bank
$60,000,000
Venture capital (Series B) - 2017
Menlo Ventures Advantage Capital Partners CRV +13
Team Size
10+
Employees
$20,500,000 Debt financing
FinSMEs

Recursion Pharmaceuticals Raises $20.5M Credit Facility from Square 1 Bank

Funding Science Intelligent machines
$60,000,000 Venture capital (Series B)
TechCrunch , PE HUB

Drug discovery startup Recursion raises $60 million in Series B from Data Collective 

Funding Intelligent machines Health
$4,000,000 Debt financing
FinSMEs

Recursion Pharmaceuticals Receives $4M Credit Facility from Square 1 Bank

$2,150,000 Venture capital (Series A)
businesswire

Recursion Raises Additional Funding, Bringing Total Series A to $15.05M for Drug Discovery | Business Wire

$12,900,000 Venture capital (Series A)
businesswire , FinSMEs

Recursion Pharmaceuticals Raises $13M to Discover New Drugs Using Artificial Intelligence | Business Wire